Strategic partnerships Novogenia has recently expanded collaboration with a U.S. partner, 10X Health System, to broaden its genetic analysis and longevity product pipeline, presenting an opportunity to position joint go-to-market initiatives, cross-sell personalized testing, and co-branded educational campaigns to both existing and potential customers.

Expanded capabilities Launch of the MGT Plus methylation test signals a broader suite of preventive genetics offerings, enabling sales conversations around comprehensive risk assessment, lifestyle genetics, and nutrition customization to healthcare providers, wellness clinics, and direct-to-consumer channels seeking epigenetic insights.

European scale New headquarters and laboratory campus in Hallwang, Austria, indicate strengthened regional capacity and faster turnaround times for European clients, making Novogenia an attractive partner for local clinics, hospitals, and insurers seeking in-country genetic testing and preventive care solutions.

Limitless potential Continued emphasis on preventive genetic testing and personalized nutrition positions Novogenia to pursue multi-channel growth with healthcare systems, fitness and wellness networks, and corporate wellness programs targeting employee health and longevity.

Growth indicators Current revenue under one million, with expansion activities and international product launches, suggest an opportunity to engage early with Novogenia’s leadership on scalable pilot programs, co-development deals, and funding-enabled collaborations to accelerate regional and global market penetration.